Goodrx Holdings, INC Schedule 13D activist filings

Spectrum Equity entities have fully divested their beneficial ownership in GoodRx Holdings, Inc. through a pro rata distribution and subsequent open market sales.

Spectrum Equity entities have reduced their beneficial ownership in GoodRx Holdings, Inc. to 8.28% following a pro rata distribution and subsequent open market sales.

Spectrum Equity has amended its Schedule 13D filing for GoodRx Holdings, Inc., disclosing a pro rata distribution of Class A Common Stock to its limited partners and subsequent open market sales, reducing its beneficial ownership to 12.9%.

Spectrum Equity, a significant shareholder in GoodRx Holdings, Inc., has reduced its beneficial ownership to 15.9% of Class A Common Stock after distributing over 3.9 million shares to limited partners and conducting open market sales.

GoodRx Holdings, Inc. has completed the previously announced repurchase of 7 million shares of Class A Common Stock from Idea Men, LLC for $4.20 per share, reducing Idea Men's beneficial ownership to 29.1%.

GoodRx Holdings, Inc. has entered into an agreement to repurchase 7 million shares of its Class A Common Stock from Idea Men, LLC for $29.4 million, reducing the major shareholder's stake.

GoodRx Holdings, Inc. has entered into an agreement to repurchase 3 million Class A shares for $12.6 million from several Spectrum Equity funds, reducing their beneficial ownership percentage.

GoodRx Holdings, Inc. has entered into an agreement to repurchase 10 million Class A shares from Francisco Partners for $42 million, reducing Francisco Partners' beneficial ownership to 36%.